157 related articles for article (PubMed ID: 35530343)
1. Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features.
Xu L; Chang N; Yang T; Lang Y; Zhang Y; Che Y; Xi H; Zhang W; Song Q; Zhou Y; Yang X; Yang J; Qu S; Zhang J
Front Oncol; 2022; 12():883543. PubMed ID: 35530343
[TBL] [Abstract][Full Text] [Related]
2. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
Ren Z; Ding HM; Qian X; Pan SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
[No Abstract] [Full Text] [Related]
3. Clinical application of serum seven tumour-associated autoantibodies in patients with pulmonary nodules.
Hu K; Gao L; Zhang R; Lu M; Zhou D; Xie S; Fan X; Zhu M
Heliyon; 2024 May; 10(9):e30576. PubMed ID: 38765082
[TBL] [Abstract][Full Text] [Related]
4. Early detection of lung cancer by using an autoantibody panel in Chinese population.
Ren S; Zhang S; Jiang T; He Y; Ma Z; Cai H; Xu X; Li Y; Cai W; Zhou J; Liu X; Hu X; Zhang J; Yu H; Zhou C; Hirsch FR
Oncoimmunology; 2018; 7(2):e1384108. PubMed ID: 29308305
[TBL] [Abstract][Full Text] [Related]
5. Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
Du Q; Yu R; Wang H; Yan D; Yuan Q; Ma Y; Slamon D; Hou D; Wang H; Wang Q
Clin Respir J; 2018 Jun; 12(6):2020-2028. PubMed ID: 29356386
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of tumor-associated autoantibodies panel in combination with traditional tumor markers for lung cancer.
Xu Y; Zhang W; Xia T; Liu Y; Bi Z; Guo L; Xie W; Xiang Y; Xu Z; Yu Z; Li Y; Bai L
Front Oncol; 2023; 13():1022331. PubMed ID: 36874112
[TBL] [Abstract][Full Text] [Related]
7. [Early diagnosis of subtype in early clinical stage lung adenocarcinoma by using an autoantibody panel and computed tomography].
Meng QC; Gao PR; Ren PF; Song YP; Li HL
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(3):204-208. PubMed ID: 30669764
[No Abstract] [Full Text] [Related]
8. [Evaluation of the application value of seven tumor-associated autoantibodies in non-small cell lung cancer based on machine learning algorithms].
Hao Y; Wu LN; Lyu YT; Liu YZ; Qin XS; Zheng R
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Nov; 57(11):1827-1838. PubMed ID: 38008573
[No Abstract] [Full Text] [Related]
9. Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
Wang J; Shivakumar S; Barker K; Tang Y; Wallstrom G; Park JG; Tsay JC; Pass HI; Rom WN; LaBaer J; Qiu J
J Thorac Oncol; 2016 Mar; 11(3):334-45. PubMed ID: 26896032
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Malignant Pulmonary Nodules Using a Combination of Tumor-associated Autoantibodies and Computed Tomography.
Liu X; Shen Q; Wen Y; Jiang Z; Ma Z; Zeng P; He J; Liao Y; Huang Y; Huang J
Am J Clin Oncol; 2024 Apr; 47(4):149-154. PubMed ID: 38054473
[TBL] [Abstract][Full Text] [Related]
11. The Value of a Seven-Autoantibody Panel Combined with the Mayo Model in the Differential Diagnosis of Pulmonary Nodules.
Ling Z; Chen J; Wen Z; Wei X; Su R; Tang Z; Hu Z
Dis Markers; 2021; 2021():6677823. PubMed ID: 33688380
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of tumor-associated antigens and autoantibody panel combination detection in the early diagnostic of lung cancer.
Ouyang R; Wu S; Zhang B; Wang T; Yin B; Huang J; Wei W; Huang M; Zhang M; Wang Y; Wang F; Hou H
Cancer Biomark; 2021; 32(3):401-409. PubMed ID: 34151844
[TBL] [Abstract][Full Text] [Related]
13. Improvement in the performance of an autoantibody panel in combination with heat shock protein 90a for the detection of early‑stage lung cancer.
Chen Q; Zhu S; Jiao N; Zhang Z; Gao G; Zheng W; Feng G; Han W
Exp Ther Med; 2023 Feb; 25(2):82. PubMed ID: 36741915
[TBL] [Abstract][Full Text] [Related]
14. Case study of an autoantibody panel for early detection of lung cancer and ground-glass nodules.
Huo Y; Guo Z; Gao X; Liu Z; Zhang R; Qin X
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3349-3357. PubMed ID: 32648227
[TBL] [Abstract][Full Text] [Related]
15. The role of seven autoantibodies in lung cancer diagnosis.
Luo B; Mao G; Ma H; Chen S
J Thorac Dis; 2021 Jun; 13(6):3660-3668. PubMed ID: 34277058
[TBL] [Abstract][Full Text] [Related]
16. Seven tumor-associated autoantibodies as a serum biomarker for primary screening of early-stage non-small cell lung cancer.
Chen P; Lu W; Chen T
J Clin Lab Anal; 2021 Nov; 35(11):e24020. PubMed ID: 34555232
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of seven autoantibodies combined detection in the diagnosis of lung cancer.
Mu Y; Xie F; Sun T
J Clin Lab Anal; 2020 Aug; 34(8):e23349. PubMed ID: 32372513
[TBL] [Abstract][Full Text] [Related]
18. High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes.
Luo R; Zheng C; Song W; Tan Q; Shi Y; Han X
Cancer Sci; 2022 Feb; 113(2):770-783. PubMed ID: 34843149
[TBL] [Abstract][Full Text] [Related]
19. Comparison of candidate serologic markers for type I and type II ovarian cancer.
Lu D; Kuhn E; Bristow RE; Giuntoli RL; Kjær SK; Shih IeM; Roden RB
Gynecol Oncol; 2011 Sep; 122(3):560-6. PubMed ID: 21704359
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Radiomic Models Based on Low-Dose and Standard-Dose CT for Prediction of Adenocarcinomas and Benign Lesions in Solid Pulmonary Nodules.
Liu J; Xu H; Qing H; Li Y; Yang X; He C; Ren J; Zhou P
Front Oncol; 2020; 10():634298. PubMed ID: 33604303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]